BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26640147)

  • 21. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
    Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
    Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
    Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
    Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trabectedin is a promising antitumour agent for synovial sarcoma.
    Yasui H; Imura Y; Outani H; Hamada K; Nakai T; Yamada S; Takenaka S; Sasagawa S; Araki N; Itoh K; Myoui A; Yoshikawa H; Naka N
    J Chemother; 2016 Oct; 28(5):417-24. PubMed ID: 27077926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
    Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
    Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
    Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
    J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.
    Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SRC signaling is crucial in the growth of synovial sarcoma cells.
    Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
    Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
    Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
    Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial Sarcoma With Myoid Differentiation.
    Qassid O; Ali A; Thway K
    Int J Surg Pathol; 2016 Sep; 24(6):525-7. PubMed ID: 27106779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
    Schulte A; Günther HS; Phillips HS; Kemming D; Martens T; Kharbanda S; Soriano RH; Modrusan Z; Zapf S; Westphal M; Lamszus K
    Glia; 2011 Apr; 59(4):590-602. PubMed ID: 21294158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.
    Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY
    Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
    Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
    Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line.
    Xue Z; Yan H; Li J; Liang S; Cai X; Chen X; Wu Q; Gao L; Wu K; Nie Y; Fan D
    J Cell Biochem; 2012 Jan; 113(1):302-12. PubMed ID: 21913215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of SYT-SSX fusion gene detection by fluorescence in-situ hybridization for synovial sarcoma].
    Sun Y; Sun BC; Liu YX; Zhang SW; Zhao XL; Wang J; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):660-4. PubMed ID: 19094483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of TLE1 in synovial sarcoma.
    Seo SW; Lee H; Lee HI; Kim HS
    J Orthop Res; 2011 Jul; 29(7):1131-6. PubMed ID: 21319215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.